{
  "ptid_time": "005_S_0223_2009-05-06",
  "img_path": "/data/qiuhui/data/adni/images/005_S_0223/2009-05-06/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 47,026 mm³, 27.2% above the reference mean. With a Z-score of 0.73 (76.9th percentile), this represents normal volume ; hippocampal volume measures 4,742 mm³, 27.0% below the reference mean. With a Z-score of -2.16 (1.5th percentile), this represents significant atrophy; whole brain volume measures 927,780 mm³, 0.0% below the reference mean. With a Z-score of -0.01 (49.8th percentile), this represents normal volume ; entorhinal cortex volume measures 1,838 mm³, 46.9% below the reference mean. With a Z-score of -2.53 (0.6th percentile), this represents significant atrophy; fusiform gyrus volume measures 10,974 mm³, 31.9% below the reference mean. With a Z-score of -2.40 (0.8th percentile), this represents significant atrophy; middle temporal gyrus volume measures 14,053 mm³, 22.1% below the reference mean. With a Z-score of -1.96 (2.5th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 81.0 years. Gender is Female. Education: 18 years. MMSE: 27.0. Logical Memory: 9.0. APOEε4 alleles: 1.0. Biomarker levels: Pittsburgh compound B: 1.95 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows significant atrophy in the hippocampus, entorhinal cortex, fusiform gyrus, and moderate atrophy in the middle temporal gyrus—key regions affected in Alzheimer's disease. Despite a normal MMSE score (27/30), the structural changes suggest neurodegeneration. The presence of one APOE4 allele further increases Alzheimer's risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely prodromal Alzheimer's given biomarker profile).  \n\n**Confidence:** **High** (due to clear atrophy in AD-vulnerable regions, though cognitive performance is still relatively preserved).  \n\n*Note: A normal MMSE does not rule out MCI, as it is insensitive to early decline. Follow-up with more sensitive cognitive tests (e.g., MoCA) and CSF/PET biomarkers would strengthen the diagnosis.*",
  "timestamp": "2025-07-25T21:04:21.019350"
}